Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 9816074
Methods and compositions for modulating nuclease-mediated genome engineering in hematopoietic stem cells
granted -
US 9815825
Coumarin derivatives and methods of use in treating cystic fibrosis, chronic obstructive pulmonary disease, and misfolded protein disorders
granted -
US 9815870
Monomeric and bright infrared fluorescent proteins
granted -
US 9815824
Kappa opioid agonists and uses thereof
granted -
US 9814762
Targeted therapeutic proteins
granted -
US 9814771
Live attenuated classical swine fever vaccine based in genetic manipulation of a putative fusion peptide area in the virus structural glycoprotein E2
granted -
US 9814777
Targeting lipids
granted -
US 9814867
Device having titania nanotube membrane for drug delivery
granted -
US 9814695
Ophthalmic solutions for glaucoma and conjunctivitis treatment
granted -
US 9814689
Enterically coated cysteamine, cystamine and derivatives thereof
granted -
US 9814701
Compositions and methods for the treatment of macular degeneration
granted -
US 9814686
Rolled collagen carrier
granted -
CA 3018619
COMPOSITION OPHTALMIQUE COMPRENANT UNE COMBINAISON SYNERGIQUE DE GLYCOGENE ET D'ACIDE HYALURONIQUE OU D'UN SEL DE CELUI-CI
granted -
US 9808510
Method for delivering gonadotropin releasing hormone into a lumen of the intestinal tract
granted -
US 9809623
α4β7 peptide monomer and dimer antagonists
granted -
US 9808543
Iron garnet nanoparticles for cancer radiotherapy and chemotherapy
granted -
US 9808505
Suppression of malignant mesothelioma by overexpression or stimulation of endothelial protein C receptors (EPCR)
granted -
US 9808459
Inhibitors of influenza viruses replication
granted -
US 9809649
Cachexia treatment
granted -
US 9809643
Identification of antibodies specific for at least two different lyssaviruses
granted -
US 9809814
Compositions and methods of nucleic acid-targeting nucleic acids
granted -
US 9808407
Porous silica particle, method for producing the same, and cosmetic containing the same
granted -
US 9809824
CpG oligonucleotide prodrugs, compositions thereof and associated therapeutic methods
granted -
US 9809604
DGAT1 inhibitor and preparation method and use thereof
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.